Related Experiment Video
Updated: Oct 6, 2025

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer.
Roberto Corchado-Cobos1,2, Natalia García-Sancha1,2, Marina Mendiburu-Eliçabe1,2
1Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, 37007 Salamanca, Spain.
Cancer cells reprogram metabolism for growth, interacting with stromal cells. This metabolic shift fuels tumor progression and influences the tumor microenvironment, including immune cells, in breast cancer.
Area of Science:
- Oncology
- Cancer Metabolism
- Tumor Microenvironment
Background:
- Cancer is characterized by metabolic alterations enabling tumor growth.
- Oncogenic mutations in tumor cells drive proliferation and progression.
- Metabolic reorganization is crucial for cancer cells' energy demands and environmental adaptation.
Purpose of the Study:
- To review metabolic changes in breast cancer.
- To explore the interaction between tumor cells and stromal myofibroblasts.
- To understand how metabolic changes contribute to tumor growth.
Main Methods:
- Literature review focusing on metabolic alterations in cancer.
- Analysis of the interplay between tumor parenchymal cells and stromal myofibroblasts.
- Examination of nutrient exchange and microenvironmental changes.
Main Results:
- Tumor cells exhibit increased protein anabolism and synthesis for proliferation.
- Stromal myofibroblasts undergo catabolism and autophagy, supplying nutrients to tumor cells.
- Metabolic changes create a nutrient-deficient, acidic tumor interstitium, promoting growth and immune suppression.
Conclusions:
- Metabolic reprogramming is a hallmark of cancer, essential for tumor growth and progression.
- The interaction between tumor and stromal cells dictates metabolic changes.
- These metabolic shifts profoundly impact the tumor microenvironment, fostering tumor growth and immune evasion.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Metabolism
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

